Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 733

1.

Development and use of fowlpox vectored vaccines for avian influenza.

Bublot M, Pritchard N, Swayne DE, Selleck P, Karaca K, Suarez DL, Audonnet JC, Mickle TR.

Ann N Y Acad Sci. 2006 Oct;1081:193-201. Review.

PMID:
17135511
2.

Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.

Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W.

Vaccine. 2009 Jan 29;27(5):773-85. doi: 10.1016/j.vaccine.2008.11.033. Epub 2008 Nov 28.

PMID:
19041677
3.

Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.

Kapczynski DR, Esaki M, Dorsey KM, Jiang H, Jackwood M, Moraes M, Gardin Y.

Vaccine. 2015 Feb 25;33(9):1197-205. doi: 10.1016/j.vaccine.2014.12.028. Epub 2015 Jan 20.

4.

Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.

Römer-Oberdörfer A, Veits J, Helferich D, Mettenleiter TC.

Vaccine. 2008 May 2;26(19):2307-13. doi: 10.1016/j.vaccine.2008.02.061. Epub 2008 Mar 18.

PMID:
18395947
5.

Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes.

Qiao CL, Yu KZ, Jiang YP, Jia YQ, Tian GB, Liu M, Deng GH, Wang XR, Meng QW, Tang XY.

Avian Pathol. 2003 Feb;32(1):25-32.

PMID:
12745375
7.

Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge.

Bublot M, Pritchard N, Cruz JS, Mickle TR, Selleck P, Swayne DE.

Avian Dis. 2007 Mar;51(1 Suppl):498-500.

PMID:
17494618
8.

Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.

Veits J, Römer-Oberdörfer A, Helferich D, Durban M, Suezer Y, Sutter G, Mettenleiter TC.

Vaccine. 2008 Mar 20;26(13):1688-96. doi: 10.1016/j.vaccine.2008.01.016. Epub 2008 Feb 4.

PMID:
18291561
9.

Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.

Jadhao SJ, Lee CW, Sylte M, Suarez DL.

Vaccine. 2009 Oct 19;27(44):6247-60. doi: 10.1016/j.vaccine.2009.07.110. Epub 2009 Aug 15.

PMID:
19686695
10.

Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs.

Kyriakis CS, De Vleeschauwer A, Barbé F, Bublot M, Van Reeth K.

Vaccine. 2009 Apr 6;27(16):2258-64. doi: 10.1016/j.vaccine.2009.02.006. Epub 2009 Feb 12.

PMID:
19428840
11.

Protection of chickens against avian influenza with nonreplicating adenovirus-vectored vaccine.

Toro H, Tang DC.

Poult Sci. 2009 Apr;88(4):867-71. doi: 10.3382/ps.2008-00333.

PMID:
19276437
12.

Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.

Pavlova SP, Veits J, Mettenleiter TC, Fuchs W.

Vaccine. 2009 Aug 13;27(37):5085-90. doi: 10.1016/j.vaccine.2009.06.048. Epub 2009 Jun 30.

PMID:
19573638
14.

A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).

Kalhoro NH, Veits J, Rautenschlein S, Zimmer G.

Vaccine. 2009 Feb 18;27(8):1174-83. doi: 10.1016/j.vaccine.2008.12.019. Epub 2009 Jan 7.

PMID:
19135116
16.

The immune response of a recombinant fowlpox virus coexpressing the HA gene of the H5N1 highly pathogenic avian influenza virus and chicken interleukin 6 gene in ducks.

Qian C, Chen S, Ding P, Chai M, Xu C, Gan J, Peng D, Liu X.

Vaccine. 2012 Sep 28;30(44):6279-86. doi: 10.1016/j.vaccine.2012.08.008. Epub 2012 Aug 15.

PMID:
22902682
17.

Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.

Niqueux E, Guionie O, Amelot M, Jestin V.

Vaccine. 2013 Aug 28;31(38):4121-8. doi: 10.1016/j.vaccine.2013.06.074. Epub 2013 Jul 8.

PMID:
23845804
18.
19.

Development of a recombinant fowlpox virus vector-based vaccine of H5N1 subtype avian influenza.

Qiao C, Yu K, Jiang Y, Li C, Tian G, Wang X, Chen H.

Dev Biol (Basel). 2006;124:127-32.

PMID:
16447503
20.

Supplemental Content

Support Center